Antegrade vs Crossover Femoral Artery Access in the Endovascular Treatment of Isolated Below-the-Knee Lesions in Patients With Critical Limb Ischemia

Abstract

Purpose: To evaluate the safety and effectiveness of antegrade vs crossover femoral artery access in the endovascular treatment of isolated below-the-knee (BTK) lesions in patients with critical limb ischemia (CLI). Methods: Between January 2014 and December 2015, 224 high-risk patients (mean age 75.8±9.8 years; 151 men) with CLI underwent infragenicular interventions on 292 crural vessels in 3 European vascular centers. All patients had isolated TransAtlantic Inter-Society Consensus (TASC) C (n=26) or D (n=198) BTK lesions. Primary endpoints were freedom from access-related complications and technical success comparing the antegrade vs crossover access groups. Results: Balloon angioplasty was the most used treatment modality (169 vessels, 75.4%). The technical success rate was 88.4% in the entire cohort and 88.0% in the antegrade group vs 90.4% in the crossover group (p>0.99). In all patients, the technical success rate was higher for stenotic lesions (100%) vs occlusions (85.5%, p=0.002) and in patients with TASC C BTK lesions (100%) vs TASC D (86.9%, p=0.033). The overall freedom from access-related complications was 97.8%: 99% in the antegrade group and 90.6% in the crossover group (p=0.022). Larger sheath size (5/6-F vs 4-F) was associated with a significantly higher risk for access-related complications (7.1% vs 1.1%, respectively; p=0.047). Conclusion: The present multicenter study showed high technical success and a low incidence of access-related complications in the treatment of isolated BTK lesions using either antegrade or crossover femoral access. The antegrade approach with the use of a 4-F system seems to have a significantly lower rate of access-related complications.

Keywords

antegrade access anterior tibial artery balloon angioplasty below-the-knee lesions critical limb ischemia contralateral access infragenicular vessels fibular artery occlusion popliteal artery posterior tibial artery sheath size stenosis vascular access

Get full access to this article

View all access options for this article.

References

Ramsey

Newton

Blough

Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–387.

Dillingham

Pezzin

MacKenzie

EJ.

Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875–883.

Chen

Smith

Bailey

Disease location is associated with survival in patients with peripheral arterial disease. J Am Heart Assoc. 2013;2:e000304.

Veith

Moss

Fell

Comparison of expanded PTFE and vein grafts in lower extremity arterial reconstructions. J Cardiovasc Surg (Torino). 1978;19:341–344.

TASC Steering Committee, Jaff

White

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Endovasc Ther. 2015;22:663–677.

Sacks

Marinelli

Martin

; Society of Interventional Radiology Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14(9 pt 2):S395–S404.

Wheatley

Mansour

Grossman

Complication rates for percutaneous lower extremity arterial antegrade access. Arch Surg. 2011;146:432–435.

Bosiers

Deloose

Callaert

4-French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4-EVER trial. J Endovasc Ther. 2013;20:746–756.

Lichtenberg

Kolks

Hailer

PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions. J Endovasc Ther. 2014;21:373–380.

10.

Donas

Torsello

Schwindt

Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg. 2010;52:356–361.

11.

Lichtenberg

Stahlhoff

Boese

Superficial femoral artery TASC D registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia. J Cardiovasc Surg (Torino). 2013;54:433–439.

12.

Sadaghianloo

Jean-Baptiste

Declemy

Percutaneous angioplasty of long tibial occlusions in critical limb ischemia. Ann Vasc Surg. 2013;27:894–903.

13.

Jens

Conijn

Koelemay

Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 2: below the knee). Eur J Vasc Endovasc Surg. 2014;47:536–544.

14.

Yao

Wang

Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: a meta-analysis of randomized trials. J Vasc Surg. 2014:59:1711–1720.

15.

Donas

Schwindt

Schonefeld

Below-knee bare nitinol stent placement in high-risk patients with critical limb ischemia and unlimited supragenicular inflow as treatment of choice. Eur J Vasc Endovasc Surg. 2009;37:688–693.

16.

Bosiers

Scheinert

Peeters

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390–398.

17.

Bisdas

Borowski

Torsello

; First-Line Treatments in Patients With Critical Limb Ischemia (CRITISCH) Collaborators. Current practice of first-line treatment strategies in patients with critical limb ischemia. J Vasc Surg. 2015;62:965–973.